Antibody ID
|
Number of clones
|
VH
| | | |
VL
| | | |
---|
| |
Total NT substitution (%)
|
R/S ratio in Frame work
|
R/S ratio in CDR regions
|
Strong Selection On HCDR
|
Total NT substitution (%)
|
R/S ratio in Frame work
|
R/S ratio in CDR regions
|
Strong Selection on LCDR
|
---|
1A2
|
1
|
6.08%
|
4/2
|
10/2
|
Yes
|
0.34%
|
0/0
|
1/0
|
No
|
1A4
|
1
|
6.08%
|
3 /4
|
11/0
|
Yes
|
2.05%
|
1/0
|
4/1
|
Yes
|
1A6
|
6
|
8.59%
|
7/2
|
15/1
|
Yes
|
3.97%
|
2/1
|
8/1
|
Yes
|
1A10
|
1
|
6.46%
|
5/5
|
7/2
|
Yes
|
2.72%
|
0/1
|
7/0
|
Yes
|
1B1
|
1
|
1.36%
|
2/1
|
1/0
|
No
|
1.04%
|
0/0
|
3/0
|
No
|
1B2
|
2
|
4.42%
|
2/2
|
8/1
|
Yes
|
2.82%
|
3/0
|
4/0
|
Yes
|
1C3
|
1
|
5.78%
|
4/2
|
11/0
|
Yes
|
2.03%
|
1/1
|
4/0
|
Yes
|
1C4
|
2
|
5.48%
|
2/1
|
12/1
|
Yes
|
2.38%
|
5/2
|
0/0
|
No
|
1C6
|
1
|
3.75%
|
1 /2
|
8/0
|
Yes
|
2.37%
|
0/1
|
5/1
|
Yes
|
1D4
|
1
|
6.16%
|
5/4
|
9/0
|
Yes
|
3.64%
|
0/3
|
8/0
|
Yes
|
1D7
|
1
|
7.43%
|
5/3
|
14/0
|
Yes
|
2.74%
|
0/1
|
6/1
|
Yes
|
- Note: Antigen-driven selection on HCDR and LCDR regions was judged based on somatic mutation analysis method developed by Shlomchik M et al. [27]